-
Domestic Viagra Baiyunshan Jinge released clinical data
Time of Update: 2015-02-14
On January 24, 2015, sponsored by Chinese society of sexuality, sexology research center of Peking University Medical Department, Wu Jieping medical foundation, andrology branch of Chinese Medical Ass
-
Conbercept, a new drug of Kanghong pharmaceutical industry, makes the world amazing
Time of Update: 2015-02-13
Chinese ophthalmologists reported in the United States Monday that their clinical trials showed that conbercept, a new drug independently developed by Chengdu Kanghong Pharmaceutical Co., could signif
-
Professor Hao Jihui has successfully developed nano carrier drugs for pancreatic cancer
Time of Update: 2015-02-12
According to the "Symposium on the application of gene detection technology in the individualized diagnosis and treatment of tumor" held in Tianjin recently, the research group led by Professor Hao J
-
Insight: CDE drug review report in January 2015
Time of Update: 2015-02-12
Guide: chemical 1.1 new drug added SGLT2 inhibitor, Zhengda Tianqing subsidiary declared that clozatinib, a major special anticancer new drug with micro core in Shenzhen, has obtained the production a
-
Feishuiliuwairentian cbmg acquires car-t immunotherapy of PLA General Hospital
Time of Update: 2015-02-10
On February 9, cbmg announced the acquisition of car-t cell therapy of PLA General Hospital (301 Hospital) The acquisition includes CD19, CD20, CD30, recombinant expression vector of human epidermal g
-
Meibairui, a subsidiary of Rongchang biology, creates the largest cro and CMO company in Asia
Time of Update: 2015-02-10
Recently, the official website of the Ministry of science and technology of the people's Republic of China announced "a new class I drug independently developed by Yantai Rongchang Pharmaceutical Co.
-
Merck xuelanuo soft tissue sarcoma drug th-302 approved for domestic clinical use
Time of Update: 2015-02-10
Merck xuelanuo's soft tissue sarcoma drug th-302 was approved for clinical use in China on February 5, 2015, and its current status is "under approval" Th-302, developed by threshold and Merck, is use
-
The rise of traditional Chinese medicine "Longjiang team" new drugs has generated more than 2 billion yuan in total
Time of Update: 2015-02-10
Traditional Chinese medicine often gives people a bitter taste, and the day-to-day, boring work in the pharmaceutical research laboratory is a bit "bitter" However, in the school of medicine of Heilon
-
Patent analysis and application to assist new drug research and development of Laimei pharmaceutical
Time of Update: 2015-02-09
What's the status of competitors' patents?
How to avoid and bypass others' existing patents?
-
Analysis of the current situation of the approval of generic drugs in China
Time of Update: 2015-02-08
According to the drug intelligence registration and acceptance database, we first screened out the drugs with the application type of imitation or the existing national standards, and further excluded
-
2014 chemical registration application ranking
Time of Update: 2015-02-08
For drug registration application, 2014 was a busy year In 2014, drug review center accepted 8789 new registration applications (calculated by acceptance number, excluding reexamination), an increase
-
Analysis report on drug acceptance in 2014
Time of Update: 2015-02-08
According to the latest statistics of drug intelligence registration and acceptance database, in 2014, drug review center accepted 8789 new registration applications (calculated by acceptance number,
-
Analysis report of CDE drug review in January 2015
Time of Update: 2015-02-08
Attention: the 1.1 class of new drugs, DTRMHS-07, approved by the state's new drug, Sida, is listed as the 1.1 new drug of Zhejiang Hai Zheng pharmaceutical company The declaration is accepted by 1.1
-
Guangzhou Institute of biomedicine and health completed the pre clinical study of AD drug gibh130
Time of Update: 2015-02-07
China Academy of Sciences Guangzhou Institute of biomedicine and health was informed that the Hu Wenhui research group of the hospital has completed the preclinical study of GIBH130, a candidate drug
-
"CHP waters joint open laboratory" unveils the introduction of advanced technology into the composition analysis of traditional Chinese Medicine
Time of Update: 2015-02-06
"CHP waters joint open laboratory" is located in the experimental building of Beijing Zhendong Guangming Pharmaceutical Research Institute, covering an area of about 400 square meters It is understood
-
The follow-up momentum of three new drug varieties approved by HISCO in half a month is not decreasing
Time of Update: 2015-02-06
Sichuan hisic, a subsidiary of Tibet hisic Pharmaceutical Group Co., Ltd., recently received the approval document for drug registration issued by CFDA for the national class 6 chemical drug "Flupenti
-
Hpatinib, a new drug of Hengrui medicine, has a flat performance in the full moon
Time of Update: 2015-02-06
As of January 25, apatinib, a national first-class new drug developed by Hengrui Pharmaceutical Co., Ltd in Lianyungang, has been on the market for one month, with flat performance As expected, arixib
-
Nanofloxacin malate, a class 1 new drug of Zhejiang medicine, is expected to obtain production approval within half a year
Time of Update: 2015-02-05
According to the information of the State Food and Drug Administration (CFDA), a class of new drug, nynorfloxacin malate and its capsule preparation, which has attracted much market attention, have en
-
CDE drug review weekly report (January 26, 2015 to February 1, 2015)
Time of Update: 2015-02-05
There are 34 drugs that enter the approval process in this week, including 24 chemicals, 3 traditional Chinese medicines, 3 biological products for treatment and 4 biological products for prevention T
-
Clinical approval for olacetam, a 6-class chemical of qingyutang pharmaceutical
Time of Update: 2015-02-05
Fu'an pharmaceutical announced today that its subsidiary, qingyutang pharmaceutical's olacetam capsule, recently received the approval for clinical trials of drugs issued by the State Food and drug ad
